Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
Titel:
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
Auteur:
Cremolini, C. Loupakis, F. Antoniotti, C. Lonardi, S. Masi, G. Salvatore, L. Cortesi, E. Tomasello, G. Spadi, R. Zaniboni, A. Tonini, G. Barone, C. Vitello, S. Longarini, R. Bonetti, A. D'Amico, M. Di Donato, S. Granetto, C. Boni, L. Falcone, A.